Buy Crypto Markets Spot FuturesBTC Earn Event Centre Rewards Hub

Parabilis Medicines, Inc. (PBLS)

NASDAQ

$35.96

$-0.69

(-1.88%)

Pre-Market

Parabilis Medicines, Inc. (PBLS) Live Price Chart

Last updated: ⁦2026-09-16 09:04:20⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Parabilis Medicines, Inc. (PBLS) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $35.96, with a market capitalisation of $4.47B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $24.51 to $41.49. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$4.47B
Open	$36.65
Day's High	$41.49
Day's Low	$24.51
Previous Close	$35.72
Volume	1.82K
Average Volume	522.16K
P/E Ratio	--
52-Week High	$41.49
52-Week Low	$24.51
Dividend Yield	--
Earnings Date	--

Parabilis Medicines, Inc. (PBLS) Pre-Market Stock Price

Parabilis Medicines, Inc. (PBLS) is trading at $35.96 in pre-market trading as of 2026-09-16 08:17:00, up 0.66% ($0.24) from the previous close of $35.72

Pre-market trading shows how investors are pricing PBLS before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.

Parabilis Medicines, Inc. (PBLS) 7-Day Stock Price Change

Over the past seven days, Parabilis Medicines, Inc. (PBLS) moved from $40.42 to $35.96, representing a decline of 11.04% ($4.46).

The stock traded between $35.24 and $41.19 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 488.71 thousand shares, up versus the previous seven-day period, indicating higher trading activity.

PBLS 52-Week Price Position

Position in Range: 67.4%

52W Low$24.51

52W High$41.49

PBLS is currently trading at $35.96, placing it 67.4% of the way from its 52-week low of $24.51 to its 52-week high of $41.49. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Parabilis Medicines, Inc. (PBLS)?

Parabilis Medicines Inc s a clinical-stage biopharmaceutical company. It is focused on the development of medicines targeting protein interactions associated with human diseases. It uses a proprietary platform to develop stabilized helical peptide therapeutics, referred to as Helicons, designed to bind and modulate specific proteins. Its flagship product candidate, zolucatetide, targets the interaction between β-catenin and the T-cell factor (TCF) family of transcription factors within the Wnt/β-catenin signaling pathway, which is associated with cell proliferation and differentiation in multiple cancer types.

Parabilis Medicines, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Exchange	NASDAQ
Company Website	https://www.parabilismed.com

How to Buy Parabilis Medicines, Inc. (PBLS) Stock on MEXC

Eligible investors can buy real shares of Parabilis Medicines, Inc. (PBLS) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for PBLS and Place Your Order

Open the RealStocks trading page and search for PBLS. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Parabilis Medicines, Inc. (PBLS) stock price today?

Parabilis Medicines, Inc. (PBLS) is currently trading at $ 35.96, up 0.66% ($0.24) from the previous close of $ 35.72. Intraday prices update in real time during regular trading hours.

2.Is PBLS stock going up or down today?

As of 2026-09-16 08:17:00, PBLS is trading at $ 35.96, up 0.66% ($0.24) from its previous close of $ 35.72. The stock has traded between $ 24.51 and $ 41.49 during today’s regular session. Past price movements do not guarantee future results.

3.What is PBLS pre-market price?

As of 2026-09-16 08:17:00, PBLS is trading at $ 35.96 in pre-market trading, up 0.66% ($0.24) from the previous close of $ 35.72. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is PBLS after-hours price?

As of 2026-09-16 08:17:00, PBLS is trading at $ 36.87 in after-hours trading, up 3.23% ($1.15) from the regular-session close of $ 35.72. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is PBLS stock trading now?

PBLS trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does PBLS sit relative to its 52-week high and low?

Over the past 52 weeks, PBLS has traded between a low of $ 24.51 and a high of $ 41.49. At $ 35.96, the stock is positioned 67.4% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Parabilis Medicines, Inc. in?

Parabilis Medicines, Inc. (PBLS) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Parabilis Medicines, Inc.'s market capitalisation and where is it listed?

Parabilis Medicines, Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 4.47B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is PBLS valued in terms of P/E ratio and EPS?

PBLS trades at a P/E ratio of --, based on trailing-twelve-month EPS of --. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Parabilis Medicines, Inc. pay a dividend?

Parabilis Medicines, Inc. pays an indicated annual cash dividend of -- per share, with a current dividend yield of --% based on the latest share price. Dividend policies are subject to change at the board's discretion.